Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07062016
Status
Recruiting
Apply to this trial

Conditions

  • Endometrial Carcinoma
  • Endometrial High Grade Endometrioid Adenocarcinoma
  • Stage II Endometrial Cancer
  • Stage III Endometrial Cancer
  • Stage IV Endometrial Cancer

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study seeks to better understand the recurrence of high-risk endometrial cancer. It will collect information about cancer genetics to find out various hereditary or cancer specific genetic variants that may have a role in diagnosis or management and prognosis of cancer. It also seeks to develop a genetic results and medical record databank for future studies.

Key Dates

Start date
Oct 1, 2025
Status verified
Apr 2026
Primary completion
Oct 31, 2028
Completion
Oct 31, 2028

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Observational
    Patients undergo blood and tissue sample collection and have their medical records reviewed throughout the study.

Primary Outcome Measure

Recurrence-free survival (RFS) [ Time Frame: Up to 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Clinical Trials Referral Office
[email protected]
855-776-0015
Evelyn A. Reynolds, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By condition
Endometrial cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies